Pembrolizumab-Mediated Complete Remission of a PLA2R-Positive Paraneoplastic Membranous Nephropathy: A Case Report
Management of paraneoplastic membranous nephropathy (MN) is directed toward the underlying malignancy, and prescriptions of immune checkpoint inhibitors (ICIs) are skyrocketing in the field of oncology. However, this drug category is usually discouraged for patients with autoimmune disorders (AIDs)...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2025-04-01
|
| シリーズ: | Kidney Medicine |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2590059525000032 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|